The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis
Abstract
Background. The long-term use of methamphetamine (MAMP) can result in psychosis but it is not clear why some individuals develop psychotic symptoms, while others use MAMP regularly over long periods and remain unscathed. We set out to characterize MAMP users and to examine the relationship of pre-morbid personality, pre-morbid social function and other psychiatric disorders to MAMP psychosis. Method. Four hundred and forty-five amphetamine users were recruited from a psychiatric hospital and a detention centre in Taipei, and were assessed with the Diagnostic Interview for Genetic Studies (DIGS). Their parents were interviewed with the Premorbid Schizoid and Schizotypal Traits (PSST) and the Premorbid Social Adjustment (PSA) schedules. Pre-morbid characteristics and psychiatric co-morbidity were compared between the MAMP users with a lifetime diagnosis of MAMP psychosis and those without. Results. The MAMP users with psychosis presented a clinical picture which mimicked the positive symptoms of schizophrenia: 85% had auditory hallucinations; 71% persecutory delusions; 63% delusions of reference. Compared with their non-psychotic counterparts, these MAMP users were younger at first MAMP use, used larger amounts of MAMP, had a significantly higher mean PSST score, and higher rates of major depressive disorder, alcohol dependence and antisocial personality disorder. Conclusions. Earlier and larger use of MAMP was associated with increased risk of psychosis. Our data are also compatible with the view that pre-morbid schizoid/schizotypal personality predisposes MAMP users to develop psychosis, and that the greater the personality vulnerability, the longer the psychosis will persist.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“First, it must account for the excessive dopamine neurotransmission that has been associated with the psychotic symptoms of schizophrenia.”
From Schizophrenia, myelination, and delayed corollary discharges: a hypothesis (2012) · cites this paper as [3]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Kessler, R. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830160031005 · Cited by 2,085
Diagnostic Interview for Genetic Studies
Nürnberger, J. I. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950110009002 · Cited by 2,075
Schizotaxia, schizotypy, schizophrenia.
Meehl, P. E. (1962) · American Psychologist · doi:10.1037/h0041029 · Cited by 2,036
The Prevalence of Psychiatric Disorders in Patients With Alcohol and Other Drug Problems
Ross, H. E. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800350057008 · Cited by 724
Cannabis Abuse and the Course of Recent-Onset Schizophrenic Disorders
LINSZEN, D. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040017002 · Cited by 665
Amphetamine Psychosis: A "Model" Schizophrenia Mediated by Catecholamines
Snyder, S. H. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.1.61 · Cited by 588
Heterogeneity of Psychiatric Diagnosis in Treated Opiate Addicts
Rounsaville, B. J. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290020027006 · Cited by 558
Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule
Hwu, H., Yeh, E., & Chang, L. ‐. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb08581.x · Cited by 472
Cited by
Sorted by citations
Items 101–200 of 295
Neurologic Complications of Psychomotor Stimulant Abuse
Sanchez‐Ramos, J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.02.003 · Cited by 40
Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users
McKetin, R., Gardner, J., Baker, A., Dawe, S., Ali, R. L., Voce, A., Leach, L., & Lubman, D. I. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.02.038 · Cited by 37
Prevalence and profile of methamphetamine users in adolescents at a juvenile classification home
Miura, H., FUJIKI, M., SHIBATA, A., & ISHIKAWA, K. (2006) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2006.01513.x · Cited by 37
Chronic Methamphetamine Psychosis after Long-Term Abstinence in Japanese Incarcerated Patients
Akiyama, K., Saito, A., & Shimoda, K. (2011) · American Journal on Addictions · doi:10.1111/j.1521-0391.2011.00124.x · Cited by 35
Antipsychotics for Amphetamine Psychosis. A Systematic Review
Fluyau, D., Mitra, P., & Lorthe, K. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00740 · Cited by 35
Reaction Time Variability and Related Brain Activity in Methamphetamine Psychosis
Fassbender, C., Lesh, T. A., Ursu, S., & Salo, R. E. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.028 · Cited by 35
Dinçer, M., Çeli̇k, C., Helvalı, E. E., Bodur, Ş., akçaer, E. T., Can, S. S., Uğurlu, G. K., İSLAMOĞLU, S., Kaymak, S. U., Torun, Y. T., et al. (2018) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2018.1467600 · Cited by 36
Zhu, D. H., Jiang, M., Ding, X., & Schöllhorn, W. I. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.528373 · Cited by 38
Spain, D. J., Crilly, J. L., Whyte, I. M., Jenner, L., Carr, V., & Baker, A. (2008) · Emergency Medicine Australasia · doi:10.1111/j.1742-6723.2008.01066.x · Cited by 34
Rognli, E. B., Berge, J., Håkansson, A., & Bramness, J. G. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.08.032 · Cited by 34
Is Schizophrenia Associated with Narcolepsy?
Walterfang, M., Upjohn, E. J., & Velakoulis, D. (2005) · Cognitive and Behavioral Neurology · doi:10.1097/01.wnn.0000160822.53577.2c · Cited by 32
Salo, R. E., Fassbender, C., Iosif, A., Ursu, S., Leamon, M. H., & Carter, C. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.06.030 · Cited by 30
Understanding the Relationship Between Amphetamines and Psychosis
Rognli, E. B., & Bramness, J. G. (2015) · Current Addiction Reports · doi:10.1007/s40429-015-0077-4 · Cited by 29
Kuitunen‐Paul, S., Roessner, V., Basedow, L. A., & Golub, Y. (2020) · Substance Abuse · doi:10.1080/08897077.2020.1806183 · Cited by 28
Wang, L., Lin, S., Chen, Y., Huang, M., Chen, T., Ree, S., & Chen, C. (2016) · Psychopathology · doi:10.1159/000445065 · Cited by 28
Self-citationRognli, E. B., Håkansson, A., Berge, J., & Bramness, J. G. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.07.037 · Cited by 27
Gan, H., Zhao, Y., Jiang, H., Zhu, Y., Chen, T., Tan, H., Zhong, N., Du, J., & Zhao, M. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00551 · Cited by 28
Fan, C., Tan, H. K., Chien, I., & Chou, S. (2014) · American Journal on Addictions · doi:10.1111/j.1521-0391.2014.12090.x · Cited by 26
Epidemiological Characteristics and Risk Factors of Methamphetamine—Associated Psychotic Symptoms
Su, M.-F., Liu, M.-X., Li, J., Lappin, J., Li, S., Wu, P., Liu, Z., Shi, J., Lü, L., & Bao, Y. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00489 · Cited by 25
Ricci, V., Salvo, G. D., & Maina, G. (2021) · Journal of Addictive Diseases · doi:10.1080/10550887.2021.1945398 · Cited by 26
Brain levels of neuropeptides in human chronic methamphetamine users
Frankel, P. S., Alburges, M. E., Bush, L. G., Hanson, G. R., & Kish, S. J. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.009 · Cited by 25
Is Dopamine Neurotransmission Altered in Prodromal Schizophrenia? A Review of the Evidence
Bauer, M., Praschak-Rieder, N., Kasper, S. F., & Willeit, M. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799958611 · Cited by 24
Substance use, microbiome and psychiatric disorders
Chivero, E. T., Sil, S., Kumar, M., & Buch, S. J. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173432 · Cited by 26
An Overview of Methamphetamine-induced Psychotic Syndromes
Zorick, T. S., Rad, D., Rim, C., & TSUANG, J. W. (2008) · Addictive Disorders & Their Treatment · doi:10.1097/adt.0b013e318066d5e0 · Cited by 23
Yamamuro, K., Kimoto, S., Iida, J., Kishimoto, N., Nakanishi, Y., Tanaka, S., Ota, T., Makinodan, M., & Kishimoto, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152373 · Cited by 23
Hartwell, E. E., Moallem, N. R., Courtney, K. E., Glasner, S. V., & Ray, L. A. (2016) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000250 · Cited by 23
Crouse, J. J., Chitty, K. M., Iorfino, F., White, D., Nichles, A., Zmicerevska, N., Guastella, A. J., Moustafa, A. A., Hermens, D. F., Scott, E. M., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210877 · Cited by 24
Lisa, P., Felicia, K., Laura, H., Daniela, K., Marlies, R., Stefanie, N., Maik, S. J., Anne, S., Maximilian, S., Kirsi, M., et al. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112505 · Cited by 23
Yang, M., Yang, C.-Q., Liu, T., & London, E. D. (2019) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2019.1676451 · Cited by 22
Bogale, T., Engidawork, E., & Yisma, E. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1145-6 · Cited by 22
Hámor, P. U., Šírová, J., Páleníček, T., Zaniewska, M., Bubeníková‐Valešová, V., & Schwendt, M. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.09.007 · Cited by 22
Recidivism among male subjects incarcerated for illicit drug use in Taiwan
Chiang, S.-C., Chan, H., CHEN, C., Sun, H., CHANG, H., Chen, W. J., Lin, S., & Chen, C. (2006) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2006.01530.x · Cited by 21
Self-citationA Review of Risk Factors for Methamphetamine-Related Psychiatric Symptoms
Chang, X., Sun, Y., Zhang, Y., Muhai, J., Lü, L., & Shi, J. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00603 · Cited by 21
Cohen-Laroque, J., Grangier, I., Perez, N., Kirschner, M., Kaiser, S., & Sabé, M. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.03.037 · Cited by 27
Dong, H., Yang, M., Liu, L., Zhang, C., Liu, M., Shen, Y., Liu, H., & Hao, W. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1346-7 · Cited by 20
Kalayasiri, R., Mutirangura, A., Verachai, V., Gelernter, J. E., & Malison, R. T. (2009) · Asian Biomedicine · doi:10.5372/abm.v3i6.268 · Cited by 20
Power, B., Stefanis, N. C., Dragović, M., Jablensky, A. V., Castle, D. J., & Morgan, V. A. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.11.003 · Cited by 19
Chen, C., Hsu, F., Li, C., & Huang, M. (2019) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2019.06.002 · Cited by 20
Self-citationRisks of psychosis in methamphetamine users: cross-sectional study in Thailand
Lamyai, W., Pono, K., Indrakamhaeng, D., Saengsin, A., Songhong, N., Khuwuthyakorn, P., Sribanditmongkol, P., Junkuy, A., & Srisurapanont, M. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-032711 · Cited by 19
Salo, R. E., NORDAHL, T. E., Leamon, M. H., Natsuaki, Y., Moore, C. D., Waters, C., & Carter, C. S. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2007.04.018 · Cited by 18
Park, T. M., & Haning, W. (2016) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2016.02.004 · Cited by 18
Fan, C., Tan, H. K., Chien, I., & Chou, S. (2013) · American Journal on Addictions · doi:10.1111/j.1521-0391.2013.12090.x · Cited by 18
Club Drugs and Psychiatric Sequelae: An Issue of Vulnerability and Previous Psychiatric History
Martinotti, G., del Villar, C. M., Cordoba, A. G., Tubau, L. A., Sánchez, I. C., Carlo, F. D., Chiappini, S., Pettorruso, M., Schifano, F., & Giannantonio, M. D. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18136944 · Cited by 18
Psychopathology in Substance Use Disorder Patients with and without Substance-Induced Psychosis
Zhornitsky, S., Tikàsz, A., Rizkallah, É., Chiasson, J., & Potvin, S. (2015) · Journal of Addiction · doi:10.1155/2015/843762 · Cited by 18
Drug‐associated psychoses and criminal responsibility
Carroll, A., McSherry, B., Wood, D. A., & Yannoulidis, L. L. B. S. (2008) · Behavioral Sciences & the Law · doi:10.1002/bsl.817 · Cited by 17
Willi, T. S., Honer, W. G., Thornton, A. E., Gicas, K. M., Procyshyn, R. M., Vila‐Rodriguez, F., Panenka, W. J., Aleksić, A., Leonova, O., Jones, A. A., et al. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.04.059 · Cited by 17
The fast and furious : Cocaine, amphetamines and harm reduction
Grund, J., Coffin, P. O., Jauffret‐Roustide, M., Dijkstra, M., DeBruin, D. A., & Blanken, P. (2010) · Cited by 16
Kalayasiri, R., Kraijak, K., Maes, M. H. J., & Mutirangura, A. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1371-7 · Cited by 17
The implications of sleep disruption for cognitive and affective processing in methamphetamine abuse
Lipinska, G., Timol, R., & Thomas, K. G. F. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.09.010 · Cited by 16
Li, J., Jiang, W. A., Zhu, R., Fan, F., Fu, F., Wei, D., Tang, S., Tian, Y., Chen, J., Li, Y., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.09.064 · Cited by 14
Does accumulating exposure to illicit drugs bring forward the age at onset in schizophrenia?
Power, B., Dragović, M., Jablensky, A. V., & Stefanis, N. C. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412461957 · Cited by 15
Environmental risk factors for schizophrenia: implications for prevention
Stilo, S. A., Forti, M. D., & Murray, R. M. (2011) · Neuropsychiatry · doi:10.2217/npy.11.42 · Cited by 15
Self-citationRelationships Among Depression, PTSD, Methamphetamine Abuse, and Psychosis
Lecomte, T., Paquin, K., Mueser, K. T., MacEwan, G. W., Goldner, E. M., Thornton, A. E., Brink, J., Lang, D. J., Kang, S., Barr, A. M., et al. (2013) · Journal of Dual Diagnosis · doi:10.1080/15504263.2013.778930 · Cited by 15
Smirnov, A., Kemp, R., Wells, H., Legosz, M., & Najman, J. M. (2014) · Social Science Research · doi:10.1016/j.ssresearch.2014.01.003 · Cited by 15
Schizophrenia and Substance Abuse Co-Morbidity
O’Daly, O., Guillin, O., Tsapakis, E.-M., Martínez, D., Shergill, S. S., Murray, R. M., & Buckley, P. F. (2005) · Journal of Dual Diagnosis · doi:10.1300/j374v01n02_03 · Cited by 15
Self-citationSynthesis of deuterium labeled phenethylamine derivatives
Xu, Y.-Z., & Chen, C. (2006) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.1139 · Cited by 15
Self-citationU.S. trends in methamphetamine-involved psychiatric hospitalizations in the United States, 2015–2019
Calcaterra, S. L., Yamkovoy, K., Swathi, P. A., Ciccarone, D., del Pozo, B., Englander, H. L., Wang, J., & Barocas, J. A. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2024.111409 · Cited by 14
Wang, L., Chiang, S.-C., Su, L., Lin, S., & Chen, C. (2012) · Substance Use & Misuse · doi:10.3109/10826084.2012.690812 · Cited by 14
Self-citationChen, C., Lin, S., Huang, M., Su, L., Hsiao, C., Chiang, Y.-L., Ree, S., Chiang, S.-C., & Liu, H. (2007) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2007.01696.x · Cited by 14
Self-citationChen, Y., Wang, L., Lin, S., & Chen, C. (2015) · Substance Use & Misuse · doi:10.3109/10826084.2015.1050110 · Cited by 14
Self-citationStimulants: Amphetamines and Cocaine
(2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-387-25733-0_5 · Cited by 14
Typologies of positive psychotic symptoms in methamphetamine dependence
Bousman, C., McKetin, R., Burns, R. A., Woods, S. P., Morgan, E. E., Atkinson, J. H., Everall, I., & Grant, I. (2015) · American Journal on Addictions · doi:10.1111/ajad.12160 · Cited by 13
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.013 · Cited by 12
Selemon, L. D., Begović, A., Williams, G. V., & Castner, S. A. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.06.002 · Cited by 11
Le, S. M., Trouiller, P., Thi, H. D., Hai, O. K. T., Minh, K. P., Vallo, R., Rapoud, D., Quillet, C., Nguyen, T. L., Nguyen, Q. D., et al. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108334 · Cited by 11
Ferraro, L., Murray, R. M., Forti, M. D., Quattrone, D., Tripoli, G., Sideli, L., Barbera, D. L., & Cascia, C. L. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.06.004 · Cited by 10
Self-citationMethamphetamine-Associated Psychosis: A Model for Biomarker Discovery in Schizophrenia
Bousman, C., Glatt, S. J., Everall, I., & Tsuang, M. T. (2011) · Springer eBooks · doi:10.1007/978-94-007-0837-2_15 · Cited by 10
Environmental Risk Factors for Schizophrenia
McGrath, J. J., & Murray, R. M. (2010) · Wiley eBooks · doi:10.1002/9781444327298.ch11 · Cited by 10
Self-citationKitanaka, N., Kitanaka, J., Hall, F. S., Kayama, M., Sugimori, H., Uhl, G. R., & Takemura, M. (2015) · Journal of Experimental Neuroscience · doi:10.4137/jen.s27733 · Cited by 9
Leposavić, L., Dimitrijević, D., Đorđević, S., Leposavić, I., & Balkoski, G. N. (2015) · PubMed · Cited by 9
Goldstone, E., Farhall, J., & Ong, B. (2011) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2011.00264.x · Cited by 9
Cannabis and Amphetamine-type Stimulant-induced Psychoses: A Systematic Overview
Alharbi, F., & el‐Guebaly, N. (2016) · Addictive Disorders & Their Treatment · doi:10.1097/adt.0000000000000086 · Cited by 9
Brummelte, S., Grund, T., Czok, A., Teuchert, G., & Neddens, J. (2006) · Behavioral and Brain Functions · doi:10.1186/1744-9081-2-12 · Cited by 9
Beyond the first episode: Candidate factors for a risk prediction model of schizophrenia
Murphy, B. (2010) · International Review of Psychiatry · doi:10.3109/09540261003661833 · Cited by 7
Embedded Ring Injury of the Middle Finger in an Amphetamine Abuser
Zeng, B.-W., Guo, Y.-J., & Huang, C.-C. (2006) · Journal of the Chinese Medical Association · doi:10.1016/s1726-4901(09)70122-4 · Cited by 8
Schizophrenia and related disorders
Murray, R. M., & Dean, K. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544125.014 · Cited by 8
Self-citationFactors Associated with Psychotic and Depressive Symptoms in Methamphetamine Users
Karabulut, S. (2023) · Iranian Journal of Psychiatry · doi:10.18502/ijps.v19i1.14334 · Cited by 7
Saarinen, A. I. L., Granö, N., & Lehtimäki, T. J. (2020) · Cognitive Therapy and Research · doi:10.1007/s10608-020-10142-z · Cited by 7
Casserly, L., Garton, D. R., Montaño-Rodriguez, A., & Andressoo, J. (2023) · Biomolecules · doi:10.3390/biom13091428 · Cited by 7
Stimulant Dependence and Stimulant-Associated Psychosis
Gilder, D. A., Gizer, I. R., Lau, P., & Ehlers, C. L. (2014) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000039 · Cited by 7
Breaking Bad Delirium: Methamphetamine and Boric Acid Toxicity with Hallucinations and Pseudosepsis
Johnson, K., Stollings, J. L., & Ely, E. W. (2017) · Southern Medical Journal · doi:10.14423/smj.0000000000000599 · Cited by 7
Methamphetamine Use and Child Welfare: Review and Research Agenda
Smith, B. D. (2008) · Journal of Public Child Welfare · doi:10.1080/15548730802523265 · Cited by 7
Gao, Z., Winhusen, T. M., Gorenflo, M. P., Dorney, I., Ghitza, U. E., Kaelber, D. C., & Xu, R. (2024) · Addiction · doi:10.1111/add.16715 · Cited by 8
Physical and psychological harms of psychostimulant use
Darke, S. G., Kaye, S. S., McKetin, R., & Duflou, J. A. (2007) · Cited by 6
Chen, Y., Yang, C., Zhu, L., Li, J., Guan, F., & Chen, T. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.11.048 · Cited by 6
Substance-Induced Psychosis and Co-occurring Psychotic Disorders
Brown, H. E., Kaneko, Y. A., & Donovan, A. L. (2019) · Current clinical psychiatry · doi:10.1007/978-3-319-23961-3_7 · Cited by 6
Passchier, R. V., Stein, D. J., Uhlmann, A., van der Merwe, C., & Dalvie, S. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.01018 · Cited by 6
Visual Perception Supports Adults in Numerosity Processing and Arithmetical Performance
He, X., Zhou, X., Zhao, J. H., & Zhang, Y. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.722261 · Cited by 6
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515 · Cited by 8
Cocaine and Methamphetamine Dependence
(2011) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585629756 · Cited by 6
A Narrative Review of the Pathophysiology and Treatment of Methamphetamine-Associated Psychosis
Stacy, P. D., Frantz, J., Miller, G., Merrill, B., & Gainer, D. M. (2024) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-024-01323-y · Cited by 5
The rising tide of drug-induced psychosis
Murray, R. M., Paparelli, A., Forti, M. D., & Morrison, P. (2025) · Neuropsychiatrie · doi:10.1007/s40211-025-00541-7 · Cited by 6
Self-citationDelusions: Understanding the Un-understandable
McKenna, P. J. (2017) · Cited by 6
Dong, H.-X., Shen, Y.-D., & Hao, W. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01320-5 · Cited by 4
Montaño-Rodriguez, A., Schorling, T., & Andressoo, J. (2024) · Cells · doi:10.3390/cells13121059 · Cited by 5
Psychosis and Substance Use: Implications for Conditional Release Readiness Evaluations
Tabernik, H. E., & Vitacco, M. J. (2016) · Behavioral Sciences & the Law · doi:10.1002/bsl.2229 · Cited by 5
Weibell, M. A., Hegelstad, W. T. V., & Johannessen, J. O. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800634-4.00005-6 · Cited by 4
Factors affecting the occurrence of psychotic symptoms in chronic methamphetamine users
Nie, L., Zhaom, Z., Wen, X., Luo, W. F., Ju, T., Ren, A., Wu, B., London, E. D., & Li, J. (2018) · Journal of Addictive Diseases · doi:10.1080/10550887.2019.1661752 · Cited by 4
Rungnirundorn, T., Krusong, K., Kalayasiri, R., & Maes, M. H. J. (2021) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2021.2016957 · Cited by 4
Chronic Methamphetamine and Psychosis Pathways
Hogarth, S. J., Manning, E. E., & van den Buuse, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-67928-6_110-1 · Cited by 4
Metadata
- Authors
- CHEN, C.-K., LIN, S.-K., SHAM, P. C., BALL, D., LOH, E.-W., HSIAO, C.-C., CHIANG, Y.-L., REE, S.-C., LEE, C.-H., & MURRAY, R. M.
- Affiliations
- Chang Gung Memorial Hospital (TW)
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2003-10-30
- Volume
- 33
- Issue
- 8
- Pages
- 1407-1414
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2108964872
- Cited by
- 295
- References
- 23
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 9 · 2023: 5 · 2022: 8 · 2021: 8 · 2020: 28 · 2019: 14 · 2018: 14 · 2017: 7 · 2016: 13 · 2015: 15 · 2014: 21 · 2013: 19 · 2012: 18
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychological Medicine (publishedVersion)
- PubMed (publishedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Keywords
- methamphetamine, amphetamine psychosis, premorbid personality, schizoid personality disorder, schizotypy, psychiatric comorbidity, major depressive disorder, alcoholism, antisocial personality disorder, auditory hallucinations, persecutory delusions, delusions of reference, age at first use, dosage
- MeSH terms
- Adolescent, Adult, Alcoholism, Central Nervous System Stimulants, Antisocial Personality Disorder, Major Depressive Disorder, Depressive Disorder, Major, Disease Susceptibility, Female, Hospitals, Psychiatric, Humans, Male, Methamphetamine, Personality Assessment, Prisons, Psychiatric Status Rating Scales, Psychoses, Substance-Induced, Risk Factors, Schizoid Personality Disorder, Schizophrenia, Schizophrenic Psychology, Social Adjustment, Taiwan, Comorbidity, Causality, Amphetamine-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review